Dietary Supplementation with Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses in Elderly Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial
Influenza-like illness (ILI) remains a major cause of severe mortality and morbidity in the elderly. Aging is associated with a decreased ability to sense pathogens and mount effective innate and adaptive immune responses, thus mandating the development of protective nutraceuticals. Biobran/MGN-3, a...
Saved in:
Main Authors: | Ahmed F. Elsaid, Sudhanshu Agrawal, Anshu Agrawal, Mamdooh Ghoneum |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f5088a83e5d447798cce6bb45e21dc0a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RIG-I and MDA5 Protect Mice From Pichinde Virus Infection by Controlling Viral Replication and Regulating Immune Responses to the Infection
by: Morgan Brisse, et al.
Published: (2021) -
Foot-and-Mouth Disease Virus 3C Protease Antagonizes Interferon Signaling and C142T Substitution Attenuates the FMD Virus
by: Pathum Ekanayaka, et al.
Published: (2021) -
KDP, a Lactobacilli Product from Kimchi, Enhances Mucosal Immunity by Increasing Secretory IgA in Mice and Exhibits Antimicrobial Activity
by: Mamdooh Ghoneum, et al.
Published: (2021) -
A randomized, double-blind, placebo-controlled, multicenter study assessing the efficacy of magnesium oxide monohydrate in the treatment of nocturnal leg cramps
by: Olha Barna, et al.
Published: (2021) -
Acute Metabolic Responses to Glucose and Fructose Supplementation in Healthy Individuals: A Double-Blind Randomized Crossover Placebo-Controlled Trial
by: Max L. Eckstein, et al.
Published: (2021)